• Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Seattle Genetics Inc

+ Add to Watchlist

SGEN:US

32.0000 USD 0.9000 2.89%

As of 20:10:00 ET on 12/26/2014.

Snapshot for Seattle Genetics Inc (SGEN)

Open: 31.5500 Day's Range: 31.5000 - 32.0700 Volume: 856,299
Previous Close: 31.1000 52wk Range: 30.5000 - 55.9900 1-Yr Rtn: -19.78%

Stock Chart for SGEN

No chart data available.
  • SGEN:US 32.0000
  • 1D
  • 1M
  • 1Y
31.1000
Interactive SGEN Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for SGEN

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.5300
Est. EPS (USD) (12/2014) -0.6670
Est. PEG Ratio -
Market Cap (M USD) 3,964.53
Shares Outstanding (M) 123.89
30 Day Average Volume 1,424,074
Price/Book (mrq) 17.6039
Price/Sale (ttm) 14.0728
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/11/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for SGEN

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for SGEN

Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.

Clay B SiegallChairman/Pres/CEO/Co-FounderTodd E SimpsonChief Financial Officer
Eric L DobmeierCOO/SecretaryJean I LiuExec VP:Legal Affairs/Gen Counsel/Secy
More Company Profile & Key Executives for SGEN

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil